Yahoo Finance Press Release Source: S.A.N.E. Vax, Inc. On Monday November 8, 2010, 8:00 am EST TROY, Mont.–(BUSINESS WIRE)– In a letter addressed to Dr. Harold E. Varmus, director of the NCI, and Dr. Margaret Hamburg, FDA commissioner, Ms. Norma Erickson, president of S.A.N.E. Vax, Inc., requested that these two federal agencies recommend a reliable […]
Jab ‘turning cervical cancer into a rare disease’ and could spell end of regular smear tests
Mail Online By Daily Mail Reporter Last updated at 9:12 AM on 10th November 2010 Cervical cancer should soon be a rare disease thanks to a mass vaccination programme for young girls, according to experts. They say the illness, which is currently the second most common form of cancer among young women, could be virtually […]
NHS screening change ‘would cut smears’
BBC News 9 November 2010 By Michelle Roberts Health reporter, BBC News Women would need far fewer smears if the NHS switched to a new way of screening for cervical cancer, a Cancer Research UK scientist has said. Good uptake of the HPV vaccine that can prevent the cancer means we can now start to […]
Few Teens Finish HPV Shot Series
Just 1/3 of Teenage Girls Get All 3 HPV Shots Web MD By Denise Mann WebMD Health News Reviewed by Laura J. Martin, MD Nov. 9, 2010 — Just one-third of teenage girls actually complete all three required doses of the human papillomavirus (HPV) shot, suggesting that many teens are unprotected or underprotected from the […]
Gardasil in the Developing World
University of Queensland
Researchers at the University of Queensland Diamantina Institute have confirmed through a study in Vanuatu that a test for human papilloma virus (HPV) could help control cervical cancer in developing countries.
Early detection has proven essential in controlling cervical cancer risk in developed countries where screening programs have reduced the prevalence of the disease by about 75%. Yet cervical cancer remains the second most common cancer in women and causes approximately 275,000 deaths worldwide each year. Due to severely limited access to adequate screening, the brunt of this mortality will be borne by women in developing countries where more than 80% of new cases occur each year.
